CJC-1295 (CJC-1295 with DAC, CAS 446262-90-4) is a synthetic 30-amino-acid peptide analog derived from human growth hormone-releasing hormone (GHRH). It has a molecular weight of 3647.28 Da and is supplied as white lyophilized powder, with HPLC purity of no less than 99%. Full COA and HPLC test documentation are provided for each batch to ensure consistent quality.

Modified with DAC (Drug Affinity Complex), this peptide is capable of reversible binding to serum albumin, which significantly prolongs its half-life for laboratory research applications. Acting as a potent GHRH receptor agonist, CJC-1295 is extensively studied in preclinical research covering endocrine regulation, growth hormone release, IGF-1 synthesis, body composition analysis and anabolic metabolism.